A Predictive Model to Differentiate Between Second Primary Lung Cancers and Pulmonary Metastasis
Feiyang Zhong1, Zhenxing Liu2, Binchen Wang1
1Department of Radiology, Zhongnan Hospital of Wuhan University, No.169 Donghu Road, Wuchang District, Wuhan 430071, China.
Academic Radiology
|June 27, 2021
Summary
A new nomogram accurately differentiates second primary lung cancers (SPLCs) from pulmonary metastases (PMs) using clinical and imaging features. This tool aids in precise diagnosis for lung cancer patients.
Area of Science:
- Pulmonology
- Radiology
- Oncology
Background:
- Distinguishing second primary lung cancers (SPLCs) from pulmonary metastases (PMs) is crucial for accurate patient management.
- Current diagnostic methods may face challenges in differentiating these conditions.
Purpose of the Study:
- To develop and validate a predictive nomogram for differentiating SPLCs from PMs.
- To identify key clinical and imaging features that aid in this differentiation.
Main Methods:
- A cohort of 261 lesions from 253 patients was analyzed.
- A nomogram was developed using 195 lesions (training set) and validated on 66 lesions (validation set).
- Clinical and imaging features including age, lesion distribution, air bronchogram, contour, spiculation, and vessel convergence were assessed.
Main Results:
- Age, lesion distribution, lesion type, air bronchogram, contour, spiculation, and vessel convergence sign were significant predictors.
- The nomogram demonstrated strong performance with an area under the curve (AUC) of 0.97 in the training set and 0.92 in the validation set.
Conclusions:
- The developed nomogram effectively classifies SPLCs and PMs.
- Clinical and radiological characteristics are valuable for differentiating these lung lesions.
